Quantitative analysis of the SN in Parkinson's disease implementing 3D modeling at 7.0‐T MRI

Parkinson's disease (PD) is a neurodegenerative disorder resulting from the progressive loss of dopaminergic (DA) neurons in the substantia nigra (SN). In our previous study, attempts were made to directly visualize the SN and quantify the differences in shapes and boundaries of the SN between PD subjects and comparison to the normal control subjects using two‐dimensional T2*‐weighted 7.0‐T MRI images (Cho et al., Mov Disord, accepted for publication). However, a two‐dimensional analysis does not represent the entire SN. Therefore, to overcome the limitation of 2D analysis, we acquire 3D image of the SN. For this study, we scanned nine PD patients, along with nine age‐matched control subjects, using a research prototype 7.0‐T MRI scanner in an attempt to visualize the 3D shape of the SN and quantify differences in the volume of the SN between PD subjects and normal control subjects. The shape change of the ventrolateral boundaries of the SN in PD cases was reconfirmed in this 3D study as well as in our previous 2D study (Cho et al., Mov Disord, accepted for publication). Another interesting finding of this study was that 3D MR imaging study demonstrated the potential of the 7.0‐T MRI in the quantification of volume changes in the SN. The measured correlation analyses showed that there is age‐dependent correlation and substantially stronger unified Parkinson's disease rating scale motor score‐dependent correlation in PD patients. These results suggest that 7.0‐T 3D T2*‐weighted MR imaging could provide the quantitative estimation of volume changes in the SN in PD patients in vivo for comparison with normal controls in vivo. © 2011 Wiley Periodicals, Inc. Int J Imaging Syst Technol, 21, 253–259, 2011;

[1]  T. Hosoya,et al.  Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. , 1999, AJNR. American journal of neuroradiology.

[2]  P. Riederer,et al.  Time course of nigrostriatal degeneration in parkinson's disease , 1976, Journal of Neural Transmission.

[3]  L. Minati,et al.  Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. , 2007, AJNR. American journal of neuroradiology.

[4]  P. Hobson,et al.  Accuracy of diagnosis in patients with presumed Parkinson's disease. , 1999, Age and ageing.

[5]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[6]  J. Ehrhardt,et al.  Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. , 1990, Archives of general psychiatry.

[7]  M Hutchinson,et al.  Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. , 2000, AJNR. American journal of neuroradiology.

[8]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[9]  P D Griffiths,et al.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. , 2000, Brain : a journal of neurology.

[10]  Jeff H. Duyn,et al.  High-field MRI of brain cortical substructure based on signal phase , 2007, Proceedings of the National Academy of Sciences.

[11]  G D Pearlson,et al.  Ventricle-brain ratio, computed tomographic density, and brain area in 50 schizophrenics. , 1989, Archives of general psychiatry.

[12]  Carlo Ciulla,et al.  Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain , 2007, Journal of magnetic resonance imaging : JMRI.

[13]  John Huston,et al.  Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging , 2011, Movement disorders : official journal of the Movement Disorder Society.

[14]  K. H. Lee,et al.  Direct Visualization of Parkinson ' s Disease by In Vivo Human Brain Imaging using 7 . 0 T MRI , 2010 .

[15]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[16]  P. Maruff,et al.  An optimized method for estimating intracranial volume from magnetic resonance images , 2000, Magnetic resonance in medicine.

[17]  A. Björklund,et al.  Dopamine neuron systems in the brain: an update , 2007, Trends in Neurosciences.

[18]  S J Kish,et al.  Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.

[19]  A. Graybiel,et al.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.

[20]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[21]  N C Andreasen,et al.  A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy , 2000, Hippocampus.

[22]  S. DeKosky,et al.  Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders , 2003, Science.

[23]  Petra Schmalbrock,et al.  Enhanced gray and white matter contrast of phase susceptibility‐weighted images in ultra‐high‐field magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.

[24]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.

[25]  U. Raff,et al.  Image fusion in neuroradiology: Three clinical examples including MRI of Parkinson disease , 2007, Comput. Medical Imaging Graph..

[26]  M Hutchinson,et al.  Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra , 1999, Journal of neurology, neurosurgery, and psychiatry.